Aviance Capital Partners’s Alexion Pharmaceuticals Inc ALXN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
-5,574
| Closed | -$1.02M | – | 262 |
|
|
2021
Q2 | $1.02M | Sell |
5,574
-115
| -2% | -$21.1K | 0.18% | 139 |
|
|
2021
Q1 | $870K | Buy |
5,689
+634
| +13% | +$97K | 0.17% | 153 |
|
|
2020
Q4 | $790K | Buy |
5,055
+55
| +1% | +$8.6K | 0.16% | 145 |
|
|
2020
Q3 | $572K | Buy |
5,000
+336
| +7% | +$38.4K | 0.13% | 157 |
|
|
2020
Q2 | $523K | Buy |
+4,664
| New | +$523K | 0.13% | 160 |
|